Method for detecting bacteria according to the gram signal thereof in a complex sample
View Patent ↗The invention relates to a method for detecting the proportion of Gram-positive and Gram-negative bacteria in a complex sample. The bacteria are detected according to the Gram signal thereof. The invention enables distinction between species of Gram-positive bacteria and species of Gram-negative bacteria in a complex sample. The invention also relates to a kit for marking Gram-positive and Gram-negative bacteria, particularly for use in flow cytometry, particularly for complex samples such as human or animal microbiota samples.
1. A method for detecting, in a sample containing bacteria, the proportion of Gram-positive bacteria relative to the proportion of Gram-negative bacteria, comprising the steps of:
a) incubating the sample, simultaneously or sequentially, with:
wheat lectin (WGA) coupled to a first fluorochrome,
vancomycin coupled to a second fluorochrome emitting a fluorescence at a different wavelength from the first fluorochrome coupled to WGA,
optionally vancomycin that is not coupled to a fluorochrome,
optionally potassium chloride,
b) centrifuging the sample resulting from step a),
c) optionally washing the sample resulting from step b), and
d) measuring the fluorescence of the first and second fluorochromes of the sample resulting from step b) or c) using flow cytometry at different wavelengths to determine the proportion of Gram-positive bacteria relative to the proportion of Gram-negative bacteria in the sample.
2. The method according to claim 1 , wherein the first fluorochrome coupled to WGA is Alexa Fluor® 647 and the second fluorochrome coupled to vancomycin is 3-BODIPY-propanoic acid.
3. The method according to claim 1 , wherein the measurement step is carried out in less than 40 minutes after the end of step c).
4. The method according to claim 1 , wherein, in step a), the concentration of the wheat lectin (WGA) coupled to the first fluorochrome in the sample to be analyzed is from 5 to 100 μg/ml, and/or the final concentration of the vancomycin coupled to the second fluorochrome in the sample to be analyzed is from 0.15 to 4 μg/ml.
5. The method according to claim 1 , wherein the incubation time in step a) is from 10 to 30 minutes.
6. The method according to claim 1 , wherein the sample is a sample of human or animal microbiota.
7. A method for detecting, optionally distinguishing and identifying families, genera and/or species of Gram-positive bacteria and Gram-negative bacteria in a bacterial sample, comprising the steps of:
a) incubating the sample, simultaneously or sequentially, with:
wheat lectin (WGA) coupled to a first fluorochrome,
vancomycin coupled to a second fluorochrome emitting a fluorescence at a different wavelength from the first fluorochrome coupled to WGA,
optionally vancomycin,
optionally potassium chloride,
b) centrifuging the sample,
c) optionally washing the sample,
d) measuring the fluorescence of the sample using flow cytometry,
e) analyzing the relative fluorescences of the first and second fluorochromes, and
f) optionally distinguishing and identifying families, genera and/or species of Gram-positive and Gram-negative bacteria by comparing the relative fluorescences of the first and second fluorochromes at different wavelengths.
8. The method according to claim 7 , wherein the first fluorochrome coupled to WGA is Alexa Fluor® 647 and the second fluorochrome coupled to vancomycin is 3-BODIPY-propanoic acid.
9. A kit for detecting the proportion of Gram-positive bacteria and the proportion of Gram-negative bacteria in a bacterial sample by flow cytometry, comprising:
i. wheat lectin (WGA) coupled to a first fluorochrome,
ii. vancomycin coupled to a second fluorochrome emitting a fluorescence at a different wavelength from the first fluorochrome coupled to WGA, and
iii. optionally vancomycin,
iv. optionally potassium chloride.
10. The kit according to claim 9 , wherein the first and second fluorochromes are selected from Alexa Fluor® labelling agent, 3-BODIPY-propanoic acid or one of its derivatives, fluorescein or one of its derivatives, salts or esters, a Cy labelling agent, a CF labelling agent, or a conjugated fluorochrome.
11. The kit according to claim 10 , wherein the first fluorochrome coupled to WGA is an Alexa Fluor® labelling agent, fluorescein or one of its derivatives, salts or esters.
12. The kit according to claim 10 , wherein the second fluorochrome coupled to vancomycin is 3-BODIPY-propanoic acid or one of its derivatives, fluorescein or one of its derivatives, salts or esters.
13. The kit according to claim 10 , wherein the first fluorochrome coupled to WGA is Alexa Fluor® 647 and the second fluorochrome coupled to vancomycin is 3-BODIPY-propanoic acid.
14. The method according to claim 1 , wherein the measurement step is carried out in less than 30 minutes.
15. The method according to claim 1 , wherein, in step a), the concentration of the wheat lectin (WGA) coupled to the first fluorochrome in the sample to be analyzed is 20 μg/ml, and/or the final concentration of the vancomycin coupled to the second fluorochrome in the sample to be analyzed is 2 μg/ml.
16. The method according to claim 1 , wherein the incubation time in step a) is 15 minutes.
17. The kit according to claim 10 , wherein the second fluorochrome coupled to vancomycin is FITC.